Alvotech: Funding, Investors & Team (Sep 2026)
Alvotech is a global biopharmaceutical company, focused on developing biosimilar versions of leading monoclonal antibodies molecules. The company has six key biosimilar molecules in development and a new state-of-the-art manufacturing plant for development and commercial supply. Alvotech is investing over $500 million in the development of its pipeline and partners with leading global pharmaceutical companies to commercialize its products.
Alvotech has raised $35.0M across 1 funding round on record, the most recent an undisclosed round of $35.0M announced in Mar 2021.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Alvotech Company Profile and Key Stats
Latest funding round on record: Mar 2021.
Alvotech Funding Rounds
Alvotech Founders and Leadership Team
No contact details are on record for this team yet.
Alvotech Funding Compared to Other Biotechnology Startups
Alvotech's latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Alvotech in Biotechnology and Reykjavík
Companies Similar to Alvotech
The Oculis platform for drug delivery is a new method that aids the absorption of drugs to both the front and…
Genis is a biotechnology company headquartered in Siglufjörður, Iceland. We strive to discover, develop and…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…
Wren Bioscience is developed to give rapid, reliable bacterial identification anywhere milk safety is…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
Alvotech Funding FAQs
What does Alvotech do?
Alvotech is a global biopharmaceutical company, focused on developing biosimilar versions of leading monoclonal antibodies molecules. The company has six key biosimilar molecules in development and a new state-of-the-art manufacturing plant for development and commercial supply. Alvotech is investing over $500 million in the development of its pipeline and partners with leading global pharmaceutical companies to commercialize its products.
How much funding has Alvotech raised?
Alvotech has raised $35.0M across 1 round on record. The most recent is an undisclosed round of $35.0M announced in Mar 2021.
When did Alvotech last raise funding?
Alvotech's most recent funding round on record is an undisclosed round of $35.0M, announced in Mar 2021.
Who is the CEO of Alvotech?
Michael Altevogt is listed as CEO at Alvotech.
Where is Alvotech headquartered?
Alvotech is based in Reykjavík, Gullbringusysla, Iceland.
How many employees does Alvotech have?
Alvotech is in the 251-500 employee band.
How does Alvotech's funding compare to other Biotechnology startups?
Alvotech's latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Alvotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Alvotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.